CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Immunizations - travel vaccinations - Management
When is hepatitis B vaccine indicated?
- Travellers to areas of high or intermediate prevalence who place themselves at risk when abroad. Behaviours that place them at risk include unsafe sexual activity, injecting drug use, undertaking relief aid work, or participating in contact sports.
- Travellers who plan to remain in areas of high or intermediate prevalence for lengthy periods.
- Individuals who are travelling to visit friends or relatives with chronic hepatitis B infection.
- Families adopting children from countries with a high or intermediate prevalence of hepatitis B.
- People who may require medical care while travelling to areas of high- or moderate-endemicity.
In depth
© NHS Institute for Innovation and Improvement